Document is current

Any future updates will be listed below

Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma

Crossref DOI link: https://doi.org/10.1007/s00234-016-1769-8

Published Online: 2017-01-09

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark